3/ Thank you #colorectalcancer organizations that promoted the study & supported our recruitment: @coloncanada @yacancercanada @FightCRC @GYRIG @COLONTOWN1 Last but not least, all who participated & shared their experiences with us Find paper here:

2/ Thank you to co-authors especially @Hallie_Dau who steered this project and @hmctaggart_c, @GillSharlene, @jonathanloree Thank you to @CC_ARCC for a Seed Grant that funded this work Find paper here:

1/ Sharing latest @CCOR_Study on information needs of patients with #colorectalcancer Needs regarding treatment were largely met but we found unmet needs regarding mental health, sexual activity, nutrition/diet & work/employment. Find paper here:

In this episode of Arthritis Wellness Conversations, host @Chronic_Tips chats with Research Scientist, @maryadevera and our Patient Advisors about pregnancy, parenting and #arthritis. #ArthritisResearch 👉Watch here: https://t.co/j1Xdk8ZQs3

8/8: Our meta-analysis of the impact of sacubitril-valsartan on quality of life in patients with heart failure with reduced ejection fraction https://t.co/P5BxH4yFxz

7/8: Our meta-analysis of the impact of ivabradine on quality of life in patients with heart failure with reduced ejection fraction https://t.co/Xc9GgpC4eB

6/8: Our meta-analysis of the impact of SGLT2 inhibitors on quality of life in patients with heart failure with reduced ejection fraction https://t.co/kQiYesGAoL

5/8: Our meta-analysis looking at the impact of iron therapy on quality of life in patients with heart failure with reduced ejection fraction & iron deficiency https://t.co/2cjGnpZE7a

4/8: A look at the use & continuation of key preventive CV meds (ASA, statins, ACEI/ARB) in patients with non-obstructive CAD vs obstructive CAD & normal coronaries found in CCTA in the PROMISE RCT https://t.co/kjj37o0SWY

3/8: A look at the risk of community-acquired bacterial pneumonia with ticagrelor (which has in vitro anti-gram+ antibacterial activity) vs clopidogrel post ACS-PCI using the Alberta APPROACH registry

2/8: UBC IM Resident Dr. Eric Wong takes a look at the discharge & post-discharge use of MRAs in an EPHESUS-like population of patients with post-STEMI LV dysfunction in the VCHA STEMI database

If you're at #CCCongress, check out some of our posters! 🧵a thread 1/8 @SCC_CCS @ubcpharmacy @CORE_UBC

Are you a health professional, new to data science, and wondering where to begin? Check out the @UBCDoM’s inaugural MOC1/Mainpro+ accredited Data Science & Health event! #ubcmedDataScience #UBCCPD. Learn more and register now: https://t.co/bnrdxIVFC7

So thrilled to see our paper cited at #IDweek2020 @LaljiLab @DavidPatrickMD @CORE_UBC @ArianaSaatchi @UBC_PharGS @ubcpharmacy

#CLSAFindings💡: Social connections and hypertension in women and men: A population-based cross-sectional study of the Canadian Longitudinal Study on Aging (CLSA) https://t.co/XQZYZBKjQ2 @GerryVeenstra @AnnalijnConklin @CORE_UBC @UBCmedicine

New Pub! Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review . Hategeka C, Lynd LD. BMJ Global Health. https://t.co/2M3gLC8Fb0 @DrHategeka @ldlynd

Waking up with the sun, @IDWeek2020 & Dr. Anthony Fauci! What a great way to kick off #IDWeek2020! @CORE_UBC

Fall is here🍂and it's time for the next issue of the New CORE Times! View it here or at: https://t.co/15LX1BKFE6 @ubcpharmacy @ldlynd @Mo_Safavi @maryadevera @AnnalijnConklin @MarkTheHarrison @JacquelynCragg @Ricky_Turgeon @ploewen @peter_zed @CHEOSNews @C2E2News @BCSUPPORTUnit

The 2019 CORE Annual Report is now available! Visit our website https://t.co/77zeWB0Fgz to check out all of our achievements in 2019! @ubcpharmacy @ldlynd @Mo_Safavi @maryadevera @AnnalijnConklin @MarkTheHarrison @ploewen @peter_zed @Ricky_Turgeon @JacquelynCragg @UBC @UBC_PharGS

New Pub! The case for independent pharmacist prescribing - Arden R. Barry, @Ricky_Turgeon , 2020 https://t.co/IADibcJgFF . @ubcpharmacy